TrkB-High Prostate Cancer Model Panel for pathway-drug testing

A CRO testing service built on patient-derived prostate cancer organoids and xenografts pre-stratified for the BDNF-high/TrkB-high/p75-null signature, letting TRK-inhibitor and anti-neurotrophin developers test whether pathway blockade works in non-fusion, pathway-active prostate cancer.